Excelra launches GOBIOM+, an intuitive avatar of its flagship biomarker intelligence platform
GOBIOM+ Biomarker Database is a comprehensive biomarker database that provides information on Proteomic, Genomic, Biochemical, Imaging, Metabolite, Clinical Scoring scales and Cellular biomarkers for 18 different therapeutic areas, covering ~2900 therapeutic indications with its reported utilities like diagnosis, prognosis, monitoring disease progression, treatment response, surrogate, efficacy and toxicity. Information in GOBIOM+ biomarker database gathered from diverse sources, includes clinical trials, scientific conferences, regulatory-approved documents and literature databases.
Excelra’s data and analytics solutions empower innovation in life sciences across the value chain from molecule to market. The Excelra Edge comes from a seamless amalgamation of data, deep domain expertise and data science. The company’s multifaceted team helps harmonize large volumes of disparate unstructured data; analyze data using cutting-edge AI/ML technologies; and galvanize data-driven decisions to unlock operational efficiencies and accelerate drug development. Being an end-to-end solution provider, Excelra helps break down silos, integrate data and analytics across Omics, Clinical Trials, and RWE to uncover novel insights and opportunities. Over the last 17 years, Excelra has been the preferred data and analytics partner to over 150 clients including 15 of the top 20 large Pharma companies. To Explore the Excelra Edge - visit www.excelra.com
Excelra is hosting a series of webinars to demonstrate how clients can leverage the data from GOBIOM+ in the R&D for various indications. One can write to email@example.com to register.
Excelra is headquartered in Hyderabad with offices in Boston, Utrecht, and Bangalore.